Clinical trial
Topical Gel Anti-Fungal Agent for Tinea Unguium
NCT00253305 · MediQuest Therapeutics, Industry · Completed
Key facts
| NCT number | NCT00253305 |
|---|---|
| Title | Topical Gel Anti-Fungal Agent for Tinea Unguium |
| Official title | Phase IIB Efficacy and Safety Study of Four Topical Gel Formulations of Anti-Fungal Agents, MQX-5858, MQX-5859, MQX-5866, and MQX-5867, Versus Vehicle in the Treatment of Tinea Unguium. |
| Lead sponsor | MediQuest Therapeutics, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Onychomycosis |
| Intervention type | Drug |
| Interventions | Organogel of naftifine, 2%, Organogel of terbinafine, 6% |
| Enrollment | 75 |
| Start date | Sep 1, 2005 |
| First posted | Nov 15, 2005 |
| Last update posted | May 30, 2007 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: